
HAIs
Latest News
Latest Videos

More News

Trade name Xacduro is an antibiotic meant to treat hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by Acinetobacter baumannii.

Off-site sterilization frees up hospital space for patient care, improving hospital return on investment. This article explains why and how to go about setting up the service.

New data about an antibiotic was announced at ECCMID that can treat Pseudomonas aeruginosa and Acinetobacter baumannii infections.

“The public health emergency ending doesn't mean that infectious disease [threats] are over, whether from COVID-19 or otherwise.”

Establishing a permanent system for monitoring the persistence and emergence of dangerous pathogens is necessary, especially COVID-19.

Maintaining proper hand hygiene is crucial in ensuring our safety and that of those around us and is rightly celebrated worldwide.

To control C auris, focus on using antibiotics and improving diagnostics. New treatments in development offer hope for better management. This is the fourth and final installment in CDC's interview with the ICT.

CDC warns about Candida auris spreading if health care workers don't take preventative measures in an interview with Infection Control Today.

To prevent the spread of C auris, the CDC recommends that IPs and environmental hygienists play a critical role. In this interview, the medical scientists clarify what specific actions they should take.

To ensure the accuracy of the information concerning Candida auris, Infection Control Today has spoken with 2 medical scientists from the CDC.

The fight for infection control and prevention (IPC) should be a global effort, and conferences play a crucial role in this fight. IPC conferences occur worldwide throughout the year, and a recent one focused on updates regarding antimicrobial resistance.

Infection Control Today's® Product Locator is a monthly column highlighting some of the latest advanced technology in the infection prevention field.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending April 30, 2023.

Findings provide the first published evidence of the relationship between standard precaution adherence and the safety of health care workers and patients.

A study published in AJIC describes how one health care system implanted an initiative by their IPs to prevent the health care-acquired infections when COVID-19 loomed over their work.

Welcome to the Inside Track with Infection Control Today video series, an ongoing series of informational and how-to videos on infection control and prevention topics. This video is about hand washing (soap and water) and hand rubbing (alcohol-based hand rub).

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending April 23, 2023.

How is infection prevention different in dental offices from other health care facilities? Experts explain.

Unlike hospitals, ambulatory settings have traditionally lacked adequate infrastructure and resources to support infection prevention and monitoring.

Sulbactam-durlobactam is under priority review (PDUFA; May 29, 2023).

Numerous pathogen outbreaks have been from the water in medical facilities. So what are the dangers, and what can infection preventionists do to prevent morbidities and mortalities from occurring?

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending April 16, 2023.

Surgical site infections (SSIs) are not getting documented as often as they occur, and the financial toll could be staggering. Two experts presented about what can be done to reduce SSIs on this topic and then spoke with Infection Control Today at the Association for PeriOperative Nurses (AORN) held in San Antonio, Texas, on April 1-4, 2023.

With the focus of COVID-19, MRSA infections increased. How did the VA work to prevent this pathogen?

Central line-associated bloodstream infections (CLABSIs) or catheter-associated urinary tract infections (CAUTIs) have been increasing since the beginning of the COVID-19 pandemic. What is the IP's role in preventing them and the mortalities that sometimes accompany them?













